{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:53:39Z","timestamp":1760151219866,"version":"build-2065373602"},"reference-count":13,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T00:00:00Z","timestamp":1644710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic, neuroinflammatory and neurodegenerative disease of the central nervous system (CNS) that can present with a plethora of physical and cognitive impairments [...]<\/jats:p>","DOI":"10.3390\/diagnostics12020482","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T21:08:43Z","timestamp":1644786523000},"page":"482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial of Special Issue \u201cMultiple Sclerosis: From Diagnostic Biomarkers to Imaging and Clinical Predictors\u201d"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-4958","authenticated-orcid":false,"given":"Dejan","family":"Jakimovski","sequence":"first","affiliation":[{"name":"Buffalo Neuroimaging Analysis Center (BNAC), Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-1485","authenticated-orcid":false,"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[{"name":"Buffalo Neuroimaging Analysis Center (BNAC), Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA"},{"name":"Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY 14203, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"doi-asserted-by":"crossref","unstructured":"Jerkovic, A., Matijaca, M., Prorokovic, A., Sikic, A., Kosta, V., Curkovic Katic, A., Dolic, K., Duka Glavor, K., Soda, J., and Dogas, Z. (2022). Information Processing Speed Assessed with Letter Digit Substitution Test in Croatian Sample of Multiple Sclerosis Patients. Diagnostics, 12.","key":"ref_2","DOI":"10.3390\/diagnostics12010111"},{"doi-asserted-by":"crossref","unstructured":"Ziccardi, S., Pitteri, M., Genova, H.M., and Calabrese, M. (2021). Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study. Diagnostics, 11.","key":"ref_3","DOI":"10.3390\/diagnostics11030484"},{"doi-asserted-by":"crossref","unstructured":"Motyl, J., Friedova, L., Vaneckova, M., Krasensky, J., Lorincz, B., Blahova Dusankova, J., Andelova, M., Fuchs, T.A., Kubala Havrdova, E., and Benedict, R.H.B. (2021). Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis. Diagnostics, 11.","key":"ref_4","DOI":"10.3390\/diagnostics11030464"},{"doi-asserted-by":"crossref","unstructured":"Bernabeu-Sanz, A., Morales, S., Naranjo, V., and Sempere, A.P. (2021). Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients. Diagnostics, 11.","key":"ref_5","DOI":"10.3390\/diagnostics11030578"},{"doi-asserted-by":"crossref","unstructured":"Poulsen, E.N., Olsson, A., Gustavsen, S., Langkilde, A.R., Oturai, A.B., and Carlsen, J.F. (2021). MRI of the Entire Spinal Cord\u2014Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis. Diagnostics, 11.","key":"ref_6","DOI":"10.3390\/diagnostics11081424"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-020-0172-3","article-title":"Longitudinal analysis of cerebral aqueduct flow measures: Multiple sclerosis flow changes driven by brain atrophy","volume":"17","author":"Jakimovski","year":"2020","journal-title":"Fluids Barriers CNS"},{"doi-asserted-by":"crossref","unstructured":"Lagan\u00e0, M.M., Jakimovski, D., Bergsland, N., Dwyer, M.G., Baglio, F., and Zivadinov, R. (2021). Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software. Diagnostics, 11.","key":"ref_8","DOI":"10.3390\/diagnostics11020325"},{"doi-asserted-by":"crossref","unstructured":"Wasiuk-Zowada, D., Knapik, A., Szefler-Derela, J., Brzek, A., and Krzystanek, E. (2021). Kinesiophobia in Stroke Patients, Multiple Sclerosis and Parkinson\u2019s Disesase. Diagnostics, 11.","key":"ref_9","DOI":"10.3390\/diagnostics11050796"},{"doi-asserted-by":"crossref","unstructured":"Beck, J., Jaekel, A.K., Zeller, F.L., Kowollik, M., Kurze, I., Kaufmann, A., Feneberg, W., Brandt, A., Flachenecker, P., and Henze, T. (2022). Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis. Diagnostics, 12.","key":"ref_10","DOI":"10.3390\/diagnostics12010191"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14737175.2021.1886082","article-title":"Considering patient age when treating multiple sclerosis across the adult lifespan","volume":"21","author":"Jakimovski","year":"2021","journal-title":"Expert Rev. Neurother."},{"doi-asserted-by":"crossref","unstructured":"Ganapathy Subramanian, R., Horakova, D., Vaneckova, M., Lorincz, B., Krasensky, J., Kubala Havrdova, E., and Uher, T. (2021). Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis. Diagnostics, 11.","key":"ref_12","DOI":"10.3390\/diagnostics11122230"},{"doi-asserted-by":"crossref","unstructured":"Jewells, V.L., Yuan, H., Merrill, J.R., Frank, J.E., Patel, A., Cohen, S.M., Giglio, B., Feinberg, N.N., Matsushima, G.K., and Li, Z. (2021). Assessment of (18)F-PBR-111 in the Cuprizone Mouse Model of Multiple Sclerosis. Diagnostics, 11.","key":"ref_13","DOI":"10.3390\/diagnostics11050786"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:18:52Z","timestamp":1760134732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,13]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["diagnostics12020482"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12020482","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2022,2,13]]}}}